Bio

howard headshotDavid Howard is a faculty member in the Department of Health Policy and Management at Emory University. A health economist by training, Dr. Howard’s research employs economics and statistics to better understand physician decision-making and its implications for public policy. Dr. Howard’s current focus is on how negative results from clinical trials and “do less” recommendations from guidelines influence practice patterns. Dr. Howard has acted as an advisor or consultant to the Center for Medicare & Medicaid Services, MEDPAC, the American Cancer Society, the Division of Transplantation in the Department of Health and Human Services, and the Institute of Medicine. He is currently a member of CMS’s Medicare Evidence Development & Coverage Advisory Committee and chairs the advisory board of the National Living Donation Assistance Center. Dr. Howard received his doctorate in health policy from Harvard University in 2000.

Contact information: Department of Health Policy and Management, Emory University, 1518 Clifton Road NE, Atlanta, GA30322. (404) 727-3907, david.howard@emory.edu.

Twitter: @CostAnEffect

Selected publications

Howard DH, Soulos PR, Chagpar AB, Mougalian S, Killelea B, Gross CP. Contrary to conventional wisdom, physicians abandoned a breast cancer treatment after a trial concluded it was ineffective. Health Affairs 2016;35(7):1309-1315.

Howard DH, David G, Hockenberry J. Selective hearing: physician-ownership and physicians’ response to new evidence. Journal of Economics and Management Strategy Published online ahead of print.

Howard DH, Gross CP. Producing evidence to reduce low value care. JAMA: Internal Medicine 175(12):1893-1894.

Howard DH, Tangka F, Ekwueme D, Guy G, Lipscomb J. Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Affairs 2013;32(3):596-602.

Howard DH, Brophy R, Howell S. Evidence of no benefit from knee surgery for osteoarthritis led to coverage changes and is linked to decline in procedures. Health Affairs 2012;31(10):2242-2249.

Howard DH, Kauh J, Lipscomb J. The value of new chemotherapeutics for metastatic colorectal cancer. Archives of Internal Medicine 2010;170(6):537-542.

Fernandez JM, Stohr L, Howard DH. The effect of cadaveric kidney donations on living kidney donations: an instrumental variables approach. Economic Inquiry 2013;51(3):1696-1714.